Observational studies on the relationship between patatin-like phospholipase domain-containing protein-3 rs738409 genotype and kidney function (ordered by publication year and study population)

Author, ReferenceStudy characteristicsDiagnosis of NAFLDPNPLA3 rs738409 genotypesGlomerular filtration rate formulasStatistical adjustmentsMain results
Adults
Oniki et al. [24]Cross-sectional and retrospective longitudinal studies: 740 and 393 Japanese participants (followed for 5.5 years) respectively, during a health screening programUtrasonographyG/G: n = 139 patients; G/C: n = 399 patients; C/C: n = 202 patientsJapanese eGFR equationAge, gender, body mass index; diabetes, hypertension, dyslipidemia, fatty liverCarriers of G/G genotype and normal weight had reduced eGFR levels than those with C/C or C/G genotypes
Musso et al. [25]Cross-sectional study: 202 non-obese and non-diabetic individuals (61 with biopsy-confirmed NAFLD)BiopsyG/G or G/C: 112 patients; C/C: n = 90 patientsChronic kidney disease epidemiology (CKD-EPI) collaboration equationAge, gender, body mass index; metabolic syndromeCarriers of G/G or C/G genotypes were linked to higher risk of albuminuria and CKD than C/C genotype
Mantovani et al. [26]Cross-sectional study: 101 Caucasian post-menopausal women with type 2 diabetesFLI ≥ 60 (ultrasonography in a subset of patients)G/G: n = 8 patients; G/C: n = 41 patients; C/C: n = 52 patientsCKD-EPI collaboration equationAge, diabetes duration, hemoglobin A1c, insulin-resistance, systolic blood pressure, hypertension treatment, FLICarriers of G/G genotype had reduced eGFR levels and higher prevalence of CKD than to C/C or C/G genotypes
Sun et al. [27]Cross-sectional study: 227 Chinese patients with NAFLDbiopsyG/G: n = 14 patients; G/C: n = 31 patients; C/C: n = 30 patientsCKD-EPI collaboration equationAge, sex, body mass index; waist circumference, hyperuricemia, insulin-resistance, hypertension, diabetes, NASH, liver fibrosisPatients with NAFLD and normal liver enzymes, who carried the PNPLA3 rs738409 G allele, were at higher risk of glomerular and tubular injury
Children and adolescents
Targher et al. [28]Cross-sectional study: 142 Caucasian children and adolescents with NAFLDBiopsyG/G: n = 45 patients; G/C: n = 56 patients; C/C: n = 41 patientsBedside Schwartz equationAge, sex, systolic blood pressure, measures of adiposity, insulin-resistance, NASH, liver fibrosisCarriers of G/G genotype had reduced eGFR levels and higher proteinuria than C/C or C/G genotypes
Marzuillo et al. [29]Cross-sectional study: 591 Caucasian obese childrenUltrasonographyG/G: n = 87 patients; G/C: n = 219 patients; C/C: n = 285 patientsBedside Schwartz equationGender, duration of obesity, alanine transaminase, insulin resistance, lipidsCarriers of G/G genotype had reduced eGFR levels than those with C/C or C/G genotypes
Di Costanzo et al. [30]Cross-sectional study: 230 Caucasian overweight/obese childrenMagnetic resonance imagingG/G: n = 22 patients; G/C: n = 100 patients; C/C: n = 108 patientsBedside Schwartz equationAge, sex, pubertal status, waist circumference, diastolic blood pressure, NAFLDCarriers of G/G genotype did not have lower eGFR levels than those with C/C or C/G genotypes

FLI: fatty liver index